Molecular interaction fingerprint approaches for GPCR drug discovery

被引:37
|
作者
Vass, Marton [1 ]
Kooistra, Albert J. [1 ,2 ]
Ritschel, Tina [1 ,2 ]
Leurs, Rob [1 ]
de Esch, Iwan J. P. [1 ]
de Graaf, Chris [1 ]
机构
[1] Vrije Univ Amsterdam, Amsterdam Inst Mol Med & Syst, Div Med Chem, Boelelaan 1108, NL-1081 HZ Amsterdam, Netherlands
[2] Radboud Univ Nijmegen, Med Ctr, CMBI, Geert Grootepl Zuid 26-28, NL-6525 GA Nijmegen, Netherlands
关键词
LIGAND INTERACTION PATTERNS; FRAGMENT-LIKE LIGANDS; BINDING-SITE; HISTAMINE H-1; SC-PDB; PROTEIN; SIMILARITY; CONSENSUS; DOCKING; TARGET;
D O I
10.1016/j.coph.2016.07.007
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Protein-ligand interaction fingerprints (IFPs) are binary 1D representations of the 3D structure of protein-ligand complexes encoding the presence or absence of specific interactions between the binding pocket amino acids and the ligand. Various implementations of IFPs have been developed and successfully applied for post-processing molecular docking results for G Protein-Coupled Receptor (GPCR) ligand binding mode prediction and virtual ligand screening. Novel interaction fingerprint methods enable structural chemogenomics and polypharmacology predictions by complementing the increasing amount of GPCR structural data. Machine learning methods are increasingly used to derive relationships between bioactivity data and fingerprint descriptors of chemical and structural information of binding sites, ligands, and protein-ligand interactions. Factors that influence the application of IFPs include structure preparation, binding site definition, fingerprint similarity assessment, and data processing and these factors pose challenges as well possibilities to optimize interaction fingerprint methods for GPCR drug discovery.
引用
收藏
页码:59 / 68
页数:10
相关论文
共 50 条
  • [1] Emerging Approaches to GPCR Ligand Screening for Drug Discovery
    Kumari, Punita
    Ghosh, Eshan
    Shukla, Arun K.
    TRENDS IN MOLECULAR MEDICINE, 2015, 21 (11) : 687 - 701
  • [2] Refining GPCR Discovery Approaches
    Kerr, Ellyn
    GENETIC ENGINEERING & BIOTECHNOLOGY NEWS, 2011, 31 (08): : 14 - +
  • [3] GPCR Drug Discovery: Emerging Targets, Novel Approaches and Future Trends
    Zhou, Jia
    Wild, Christopher
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2019, 19 (16) : 1363 - 1364
  • [4] Evolving cryo-EM structural approaches for GPCR drug discovery
    Zhang, Xin
    Johnson, Rachel M.
    Drulyte, Ieva
    Yu, Lingbo
    Kotecha, Abhay
    Danev, Radostin
    Wootten, Denise
    Sexton, Patrick M.
    Belousoff, Matthew J.
    STRUCTURE, 2021, 29 (09) : 963 - +
  • [5] Tools for GPCR drug discovery
    Zhang, Ru
    Xie, Xin
    ACTA PHARMACOLOGICA SINICA, 2012, 33 (03) : 372 - 384
  • [6] Tools for GPCR drug discovery
    Ru Zhang
    Xin Xie
    Acta Pharmacologica Sinica, 2012, 33 : 372 - 384
  • [7] DRUG DISCOVERY Takeda taps Sosei for GPCR drug discovery
    Cross, Ryan
    CHEMICAL & ENGINEERING NEWS, 2019, 97 (32) : 15 - 15
  • [8] Modern molecular approaches to drug design and discovery
    Ojima, Iwao
    ACCOUNTS OF CHEMICAL RESEARCH, 2008, 41 (01) : 2 - 3
  • [9] Molecular approaches to receptors as targets for drug discovery
    Herz, JM
    Thomsen, WJ
    Yarbrough, GG
    JOURNAL OF RECEPTOR AND SIGNAL TRANSDUCTION RESEARCH, 1997, 17 (05): : 671 - 776
  • [10] Nanobodies and their Use in GPCR Drug Discovery
    Cromie, Karen D.
    Van Heeke, Gino
    Boutton, Carlo
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2015, 15 (24) : 2543 - 2557